Skip to main content
. 2022 May 24;148(8):1943–1953. doi: 10.1007/s00432-022-03975-6

Table 2.

Demographic and clinical characteristics of the study sample

Covariates Group A
N = 49 (targeted-TKI treatment, Stage IV at diagnosis)
Group B
N = 121 (no-TKI treatment, Stage IV at diagnosis or metastases)
Group C
N = 495 (no TKI, Stage I–III at diagnosis, no metastases)
Age at diagnosis (mean/SD) 58.4/12.4 60.1/9.2 63.9/9.4
Time since diagnosis in years (mean/ SD) 3.7/2.5 4.1/3.3 4.6/ 2.8
N (%) N (%) N (%)
Sex
 Male 20 (40.8) 62 (51.2) 320 (64.6)
 Female 29 (59.2) 59 (48.8) 175 (35.4)
Age groups (age in years at interview)
 < 50 5 (10.2) 2 (1.7) 9 (1.8)
 50–59 14 (28.6) 35 (28.9) 75 (15.2)
 60–69 16 (32.7) 51 (42.1) 176 (35.6)
 > 70 14 (28.6) 33 (27.3) 235 (47.5)
Smoking status (self-reported, and clinical data)
 Never 19 (38.8) 11 (9.1) 38 (7.7)
 Former 23 (46.9) 83 (68.6) 360 (72.7)
 Current 0 23 (19.0) 68 (13.7)
 Unknown 7 (14.3) 4 (3.3) 29 (5.9)
Partner
 No 6 (12.2) 31 (25.6) 81 (16.4)
 Yes 33 (67.3) 76 (62.8) 332 (67.1)
 Missing 10 (20.4) 14 (11.6) 82 (16.6)
Social well-being
 Low 9 (18.4) 30 (24.8) 145 (29.3)
 High 38 (77.6) 81 (66.9) 298 (60.2)
 Missing 2 (4.1) 10 (8.3) 52 (10.5)
Employment
 Employed 10 (20.4) 10 (8.3) 50 (10.1)
 Unemployed 0 8 (6.6) 8 (1.6)
 Housewife/man 1 (2.0) 7 (5.8) 7 (1.4)
 Disability pension 8 (16.3) 21 (17.4) 42 (8.5)
 Retired 20 (40.8) 60 (49.6) 303 (61.2)
 Not asked/unknown 10 (20.4) 15 (12.4) 85 (17.2)
Household income (in €)
 < 1000 2 (4.1) 15 (12.4) 36 (7.3)
 1000–< 2000 8 (16.3) 40 (33.1) 152 (30.7)
 2000–< 3000 8 (16.3) 27 (22.3) 107 (21.6)
 3000–< 4000 9 (18.4) 9 (7.4) 45 (9.1)
 > 4000 7 (14.3) 7 (5.8) 38 (7.7)
 Declined to report 5 (10.2) 9 (7.4) 35 (7.1)
 Not asked 10 (20.4) 14 (11.6) 82 (16.6)
Former or current occupation
 Blue collar worker 6 (12.2) 20 (16.5) 83 (16.8)
 Civil servant 4 (8.2) 5 (4.1) 31 (6.3)
 White collar worker 25 (51.0) 63 (52.1) 224 (46.9)
 Self-employed 4 (8.2) 14 (11.6) 53 (10.7)
 Missing 10 (20.4) 19 (15.7) 104 (21.0)
Education
 None to lower secondary education 13 (26.5) 56 (46.3) 246 (49.7)
 Secondary school leaving certificate 12 (24.5) 26 (21.5) 86 (17.4)
 (Professional) High school certificate 14 (28.6) 25 (20.7) 80 (16.2)
 Missing 10 (20.4) 14 (11.6) 83 (16.8)
Current treatment (self-reported)
 In treatment 23 (46.9) 21 (17.4) 15 (3.0)
 Not in treatment 16 (32.7) 86 (71.1) 399 (80.6)
 Missing 10 (20.4) 14 (11.6) 81 (16.4)
Treatment status (clinical data)
 In treatment 39 (79.6) 33 (27.3) 43 (8.7)
 Treatment ended 4 (8.2) 61 (50.4) 393 (79.4)
 Unknown 5 (10.2) 16 (14.1) 36 (7.2)
 Therapy planned 1 (2.0) 11 (9.1) 23 (4.6)
At least one comorbidity (cancer, diabetes, kidney, cardiovascular, respiratory), (self-reported + clinical data)
 No 21 (42.9) 40 (33.1) 123 (24.8)
 Yes 23 (46.9) 80 (66.1) 361 (72.9)
 Missing 5 (10.2) 1 (0.8) 11 (2.2)